Radiation Pneumonitis After Volumetric Modulated Arc Therapy for Non-small Cell Lung Cancer

被引：16

作者：

Fujiwara, Masayuki ^{[1
]}

Doi, Hiroshi ^{[1
]}

Igeta, Masataka ^{[2
]}

Suzuki, Hitomi ^{[1
]}

Kitajima, Kazuhiro ^{[1
]}

Tanooka, Masao ^{[1
]}

Ishida, Toshihisa ^{[3
]}

Wakayama, Tsukasa ^{[3
]}

Yokoi, Takashi ^{[4
]}

Kuribayashi, Kozo ^{[4
]}

Kijima, Takashi ^{[4
]}

Hashimoto, Masaki ^{[5
]}

Kondo, Nobuyuki ^{[5
]}

Matsumoto, Seiji ^{[5
]}

Hasegawa, Seiki ^{[5
]}

Kamikonya, Norihiko ^{[1
]}

Yamakado, Koichiro ^{[1
]}

机构：

[1] Hyogo Coll Med, Dept Radiol, 1-1 Mukogawa cho, Nishinomiya, Hyogo, Japan

[2] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo 3, Japan

[3] Hyogo Coll Med Coll Hosp, Dept Radiol Technol, Nishinomiya, Hyogo, Japan

[4] Hyogo Coll Med, Dept Resp Med & Hematol, Nishinomiya, Hyogo, Japan

[5] Hyogo Coll Med, Dept Thorac Surg, Nishinomiya, Hyogo, Japan

来源：

ANTICANCER RESEARCH | 2021年 / 41卷 / 11期

关键词：

Non-small cell lung cancer; chemoradiotherapy; IMRT; VMAT; radiation pneumonitis; CONCURRENT CHEMORADIOTHERAPY; RADIOTHERAPY; CHEMORADIATION; TOXICITY; INJURY;

D O I：

10.21873/anticanres.15396

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background/Aim: To evaluate the incidence and grade of radiation pneumonitis after volumetric modulated arc therapy (VMAT) performed for the treatment of non small cell cancer (NSCLC). Patients and Methods: Fifty consecutive non-surgical candidates with NSCLC underwent VMAT. Thirty-five patients had stage-III tumors and 15 had recurrent tumors. The prescribed radiation dose for the gross tumor and the elective nodal area was 69 Gy in 30 fractions and 51 Gy in 30 fractions, respectively. Results: Radiation pneumonitis developed in 38 patients (76%, 38/50), and grade >= 2 radiation pneumonitis developed in 11 patients (22%, 11/50). The percentage of lung volume that received a dose in excess of 5 Gy (V5), V10, V20, V30, and the mean lung dose (MLD) in the bilateral and ipsilateral lung were significantly associated with the development of grade >= 2 radiation pneumonitis. Conclusion: The incidence and degree of radiation pneumonitis are acceptable following treatment of NSCLC with VMAT.

引用

页码：5793 / 5802

页数：10

共 50 条

[1] Impact of Using Volumetric Modulated Arc Therapy on Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer
Imano, N.
Kimura, T.
Kameoka, T.
Ochi, M.
Takeuchi, Y.
Takahashi, I.
Nishibuchi, I.
Murakami, Y.
Kawahara, D.
Miki, K.
Saito, A.
Yasushi, N.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S635 - S635
[2] Intensity-modulated radiation therapy versus volumetric-modulated arc therapy in non-small cell lung cancer: assessing the risk of radiation pneumonitis
Rosas, Sara
Barbosa, Barbara
Couto, Jose G.
[J]. JOURNAL OF RADIOTHERAPY IN PRACTICE, 2018, 17 (01) : 6 - 11
[3] Radiation pneumonitis in lung cancer treated with volumetric modulated arc therapy
Wu, Kan
Xu, Xiao
Li, Xiadong
Wang, Jiahao
Zhu, Lucheng
Chen, Xueqin
Wang, Bing
Zhang, Minna
Xia, Bing
Ma, Shenglin
[J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (12) : 6531 - 6539
[4] Intrafraction Motion in Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy
Rossi, Maddalena M. G.
Peulen, Heike M. U.
Belderbos, Jose S. A.
Sonke, Jan-Jakob
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (02): : 835 - 843
[5] Acute Radiation Pneumonitis in Lung Cancer Treated with Volumetric Modulated Arc Therapy
Wu, Kan
Xia, Bing
Zhao, Ruping
Xu, Xiao
Wang, Bing
Xu, Lixia
Wang, Jiahao
Li, Xiadong
Wu, Zhibing
Zhang, Ke
Liang, Xiaodong
Deng, Qinghua
Ma, Shenglin
[J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S385 - S385
[6] Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patients
Imano, Nobuki
Kimura, Tomoki
Kawahara, Daisuke
Nishioka, Riku
Fukumoto, Wataru
Kawano, Reo
Kubo, Katsumaro
Katsuta, Tsuyoshi
Takeuchi, Yuki
Nishibuchi, Ikuno
Murakami, Yuji
Horimasu, Yasushi
Masuda, Takeshi
Fujitaka, Kazunori
Hattori, Noboru
Nagata, Yasushi
[J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (12) : 1729 - 1735
[7] Potential Benefits of Volumetric Modulated Arc Therapy to Reduce the Incidence of Grade 2 Radiation Pneumonitis in Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer Patients
Imano, N.
Kimura, T.
Kawahara, D.
Kubo, K.
Takeuchi, Y.
Saito, A.
Nishibuchi, I.
Murakami, Y.
Nagata, Y.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E439 - E439
[8] Sparing Functional Lung Using Optimized Volumetric Modulated Arc Therapy in Thoracic Radiation for Locally Advanced Non-Small Cell Lung Cancer
Westergaard, S. A.
Castillo, R.
Rupji, M.
Bell, J.
Castro, R.
Harms, J.
Kayode, O.
Nguyen, T.
Wolf, J.
Higgins, K. A.
Bradley, J. D.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E456 - E457
[9] Treatment Outcome and Lung Toxicities of Volumetric Modulated Arc Therapy in the Treatment of Inoperable Non-small Cell Lung Cancer Patients
Xie, C.
Jin, X.
Lin, B.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E504 - E504
[10] Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer
Ferris, Matthew J.
Martin, Katherine S.
Switchenko, Jeffrey M.
Kayode, Oluwatosin A.
Wolf, Jonathan
Dang, Quang
Press, Robert H.
Curran, Walter J.
Higgins, Kristin A.
[J]. PRACTICAL RADIATION ONCOLOGY, 2019, 9 (05) : E473 - E481

← 1 2 3 4 5 →